Nanotechnology Enables Novel Modalities for Neuromodulation
Source abstract
Abstract
Abstract Neuromodulation is of great importance both as a fundamental neuroscience research tool for analyzing and understanding the brain function, and as a therapeutic avenue for treating brain disorders. Here, an overview of conceptual and technical progress in developing neuromodulation strategies is provided, and it is suggested that recent advances in nanotechnology are enabling novel neuromodulation modalities with less invasiveness, improved biointerfaces, deeper penetration, and higher spatiotemporal precision. The use of nanotechnology and the employment of versatile nanomaterials and nanoscale devices with tailored physical properties have led to considerable research progress. To conclude, an outlook discussing current challenges and future directions for next‐generation neuromodulation modalities is presented.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neuroscience and Neural Engineering · Photoreceptor and optogenetics research · Anesthesia and Neurotoxicity Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Psychiatry and Behavioral Sciences Stanford University Stanford CA 94305 USA
Stanford Brain Organogenesis Wu Tsai Neurosciences Institute Stanford University Stanford CA 94305 USA
Wu Tsai Neurosciences Institute Stanford University Stanford CA 94305 USA
Department of Chemistry Stanford University Stanford CA 94305 USA
Microelectronics Lab (meLAB) James Watt School of Engineering University of Glasgow Glasgow G12 8QQ UK
Funding
Engineering and Physical Sciences Research Council
References (84)
Show source-provided references
1. International Neuromodulation Society https://www.neuromodulation.com/(accessed: April 2021).
2. 10.1038/s41587-019-0263-310.1038/s41587-019-0263-3 ↗
3. 10.1016/j.cell.2020.01.00110.1016/j.cell.2020.01.001 ↗
4. 10.1016/j.neuron.2016.01.04010.1016/j.neuron.2016.01.040 ↗
5. 10.1016/j.neuron.2018.05.00910.1016/j.neuron.2018.05.009 ↗
6. 10.1038/nn.362010.1038/nn.3620 ↗
7. 10.7554/eLife.1359810.7554/eLife.13598 ↗
8. 10.1038/s41586-018-0649-210.1038/s41586-018-0649-2 ↗
9. 10.1126/science.aaa961010.1126/science.aaa9610 ↗
10. 10.1038/s41582-018-0128-210.1038/s41582-018-0128-2 ↗
11. 10.1038/nn152510.1038/nn1525 ↗
12. 10.1038/nmeth.f.32410.1038/nmeth.f.324 ↗
13. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
14. 10.1038/s41587-020-0679-910.1038/s41587-020-0679-9 ↗
15. 10.1523/JNEUROSCI.1458-17.201810.1523/JNEUROSCI.1458-17.2018 ↗
16. 10.1038/3501800010.1038/35018000 ↗
17. 10.1021/acs.nanolett.9b0437310.1021/acs.nanolett.9b04373 ↗
18. Bermudes R. A. · 201710.1176/appi.books.9781615378913 ↗
19. Repetitive Transcranial Magnetic Stimulation (rTMS) Systems – Class II Special Controls Guidance for Industry and FDA Staff https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/repetitive-transcranial-magnetic-stimulation-rtms-systems-class-ii-special-controls-guidance(accessed: June 2021).
20. 10.1371/journal.pone.017842210.1371/journal.pone.0178422 ↗
21. 10.1109/TBCAS.2020.296692010.1109/TBCAS.2020.2966920 ↗
22. 10.1038/s41565-019-0487-x10.1038/s41565-019-0487-x ↗
23. 10.1038/s41563-019-0292-910.1038/s41563-019-0292-9 ↗
24. 10.1126/science.126031810.1126/science.1260318 ↗
25. 10.1002/advs.20200269310.1002/advs.202002693 ↗
26. 10.1038/s41551-017-0154-110.1038/s41551-017-0154-1 ↗
27. 10.1038/natrevmats.2016.9310.1038/natrevmats.2016.93 ↗
28. 10.1038/natrevmats.2017.7610.1038/natrevmats.2017.76 ↗
29. 10.1038/nmeth.396910.1038/nmeth.3969 ↗
30. 10.1126/scitranslmed.aax948710.1126/scitranslmed.aax9487 ↗
31. 10.1126/science.112864010.1126/science.1128640 ↗
32. 10.1038/s41565-019-0478-y10.1038/s41565-019-0478-y ↗
33. 10.1038/s41551-019-0455-710.1038/s41551-019-0455-7 ↗
34. 10.1038/nature2503210.1038/nature25032 ↗
35. 10.1126/science.aau572910.1126/science.aau5729 ↗
36. 10.1126/science.123243710.1126/science.1232437 ↗
37. 10.1126/science.aaq114410.1126/science.aaq1144 ↗
38. 10.3389/fncir.2020.0004110.3389/fncir.2020.00041 ↗
39. 10.1002/adhm.20180113210.1002/adhm.201801132 ↗
40. 10.1002/adbi.20180023310.1002/adbi.201800233 ↗
41. 10.1021/acsnano.5b0638310.1021/acsnano.5b06383 ↗
42. 10.1016/j.neuron.2015.02.03310.1016/j.neuron.2015.02.033 ↗
43. 10.1038/nmat467310.1038/nmat4673 ↗
44. 10.1038/s41551-018-0230-110.1038/s41551-018-0230-1 ↗
45. 10.1073/pnas.200235211710.1073/pnas.2002352117 ↗
46. 10.1016/j.neuron.2020.09.00310.1016/j.neuron.2020.09.003 ↗
47. 10.1016/j.brs.2018.11.00710.1016/j.brs.2018.11.007 ↗
48. 10.3171/2016.11.JNS1697610.3171/2016.11.JNS16976 ↗
49. 10.1038/nprot.2011.37110.1038/nprot.2011.371 ↗
50. 10.1073/pnas.060529410310.1073/pnas.0605294103 ↗
51. 10.1038/s41565-020-0701-x10.1038/s41565-020-0701-x ↗
52. 10.1038/ncomms346310.1038/ncomms3463 ↗
53. 10.1126/sciadv.160088910.1126/sciadv.1600889 ↗
54. 10.1109/TBME.2018.287771310.1109/TBME.2018.2877713 ↗
55. 10.1038/ncomms191410.1038/ncomms1914 ↗
56. 10.1063/5.002348610.1063/5.0023486 ↗
57. 10.1038/nnano.2008.3910.1038/nnano.2008.39 ↗
58. 10.1038/s41563-020-00896-y10.1038/s41563-020-00896-y ↗
59. 10.1038/nnano.2010.12510.1038/nnano.2010.125 ↗
60. 10.1126/science.126182110.1126/science.1261821 ↗
61. 10.1038/nmat448410.1038/nmat4484 ↗
62. 10.7554/eLife.1721010.7554/eLife.17210 ↗
63. 10.1021/acs.nanolett.9b0226610.1021/acs.nanolett.9b02266 ↗
64. 10.1016/j.cell.2015.06.05810.1016/j.cell.2015.06.058 ↗
65. 10.1038/nbt.309310.1038/nbt.3093 ↗
66. 10.1038/nn.451010.1038/nn.4510 ↗
67. 10.1038/s41551-020-0518-910.1038/s41551-020-0518-9 ↗
68. 10.1021/acsnano.5b0316210.1021/acsnano.5b03162 ↗
69. 10.1073/pnas.191438711610.1073/pnas.1914387116 ↗
70. 10.1021/acs.nanolett.6b0351710.1021/acs.nanolett.6b03517 ↗
71. 10.1126/science.aav528210.1126/science.aav5282 ↗
72. 10.2217/nnm.15.5210.2217/nnm.15.52 ↗
73. Nguyen T. · Neurotherapeutics · 2021
74. 10.1126/sciadv.abc418910.1126/sciadv.abc4189 ↗
75. IEEE Standard for Safety Levels with Respect to Human Exposure to Electric Magnetic and Electromagnetic Fields 0 Hz to 300 GHz https://standards.ieee.org/standard/C95_1-2019.html(accessed: June 2021).
76. 10.1109/TBCAS.2020.303786210.1109/TBCAS.2020.3037862 ↗
77. 10.1002/adfm.20191032310.1002/adfm.201910323 ↗
78. International Commission on Non‐Ionizing Radiation Protection Health Phys.2010 99 818.
79. 10.1038/s41565-019-0521-z10.1038/s41565-019-0521-z ↗
80. 10.1038/nn.459310.1038/nn.4593 ↗
81. 10.1038/s41551-018-0258-210.1038/s41551-018-0258-2 ↗
82. 10.1038/s41467-019-11641-810.1038/s41467-019-11641-8 ↗
83. HERMES homepage https://www.hermes-fet.eu/(accessed: April 2021).
84. Musk E. · bioRxiv · 2019 · 703801